Community-Acquired Bacterial Pneumonia (CABP)

DBCOND0049037HealthHealthcare Systems and Public Health

Community-Acquired Bacterial Pneumonia (CABP) is the indication for 3 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Community Acquired Bacterial Pneumonia · Community-Acquired Bacterial Pneumonia
Classified under
Indicated drugs

What you can answer from here — as of October 23, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Community-Acquired Bacterial Pneumonia (CABP) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In